Israel - engelsk - Ministry of Health

trima israel pharmaceutical products maabarot ltd - prasugrel - film coated tablets - prasugrel 10 mg - prasugrel - prasugrel - trima 10 mg, co-administered with acetylsalicylic acid (asa), is indicated for the prevention of atherothrombotic events in patients with acute coronary syndrome ( i.e. unstable angina, non-st segment elevation myocardial infarction [ua/nstemi] or st segment elevation myocardial infarction [stemi] undergoing primary or delayed percutaneous coronary intervention (pci). the increased efficacy should be balanced with the increased risk in patients with bleeding tendencyin those who had tia/cva in the past and in those above the age of 75 or weight below 60 kg.

Israel - engelsk - Ministry of Health

trima israel pharmaceutical products maabarot ltd - pseudoephedrine hydrochloride - tablets - pseudoephedrine hydrochloride 60 mg - pseudoephedrine - pseudoephedrine - symptomatic treatment of nasal congestion, to relieve eustachian tube congestion.

Israel - engelsk - Ministry of Health

trima israel pharmaceutical products maabarot ltd - pseudoephedrine hydrochloride - syrup - pseudoephedrine hydrochloride 30 mg / 5 ml - pseudoephedrine - pseudoephedrine - symptomatic treatment of nasal congestion, to relief eustachian tube congestion.

Israel - engelsk - Ministry of Health

trima israel pharmaceutical products maabarot ltd - eletriptan as hydrobromide - film coated tablets - eletriptan as hydrobromide 80 mg - eletriptan - acute treatment of the headache phase of migraine attacks, with or without aura

Israel - hebraisk - Ministry of Health

trima israel pharmaceutical products maabarot ltd - montelukast as sodium salt - טבליות לעיסות - montelukast as sodium salt 4 mg - montelukast - montelukast - montelukast - trima is indicated in adult and pediatric patients 2 years of age and older for the prophylaxis and chronic treatment of asthma, including prevention of daytime and nighttime symptoms, the treatment of aspirin-sensitive asthmatic patients, and the prevention of exercise-induced bronchoconstriction. montelukast - trima is effective alone or in combination with other agents used in the maintenance treatment of chronic asthma. montelukast - trima and inhaled corticosteroids may be used concomitantly with additive effects to control asthma or to reduce the inhaled corticosteroid dose while maintaining clinical stability. montelukast - trima is indicated for the relief of symptoms of seasonal allergic rhinitis in adults and pediatric patients 2 years of age and older.

Israel - hebraisk - Ministry of Health

trima israel pharmaceutical products maabarot ltd - montelukast as sodium salt - טבליות לעיסות - montelukast as sodium salt 5 mg - montelukast - montelukast - montelukast - trima is indicated in adult and pediatric patients 2 years of age and older for the prophylaxis and chronic treatment of asthma, including prevention of daytime and nighttime symptoms, the treatment of aspirin-sensitive asthmatic patients, and the prevention of exercise-induced bronchoconstriction. montelukast - trima is effective alone or in combination with other agents used in the maintenance treatment of chronic asthma. montelukast - trima and inhaled corticosteroids may be used concomitantly with additive effects to control asthma or to reduce the inhaled corticosteroid dose while maintaining clinical stability. montelukast - trima is indicated for the relief of symptoms of seasonal allergic rhinitis in adults and pediatric patients 2 years of age and older.

Israel - hebraisk - Ministry of Health

trima israel pharmaceutical products maabarot ltd - montelukast as sodium salt - טבליה - montelukast as sodium salt 10 mg - montelukast - montelukast - montelukast - trima is indicated in adult and pediatric patients 2 years of age and older for the prophylaxis and chronic treatment of asthma, including prevention of daytime and nighttime symptoms, the treatment of aspirin-sensitive asthmatic patients, and the prevention of exercise-induced bronchoconstriction. montelukast - trima is effective alone or in combination with other agents used in the maintenance treatment of chronic asthma. montelukast - trima and inhaled corticosteroids may be used concomitantly with additive effects to control asthma or to reduce the inhaled corticosteroid dose while maintaining clinical stability. montelukast - trima is indicated for the relief of symptoms of seasonal allergic rhinitis in adults and pediatric patients 2 years of age and older.

Israel - engelsk - Ministry of Health

trima israel pharmaceutical products maabarot ltd - fluconazole - solution for infusion - fluconazole 2 mg/ml - fluconazole - fluconazole - stabilanol is indicated in the following fungal infections .stabilanol is indicated in adults for the treatment of: • cryptococcal meningitis .• coccidioidomycosis. invasive candidiasis.• mucosal candidiasis including oropharyngeal, oesophageal candidiasis, candiduria and chronic mucocutaneous candidiasis.• chronic oral atrophic candidiasis (denture sore mouth) if dental hygiene or topical treatment are insufficient.stabilanol is indicated in adults for the prophylaxis of: • relapse of crytopcoccal meningitis in patients with high risk of recurrence.• relapse of oropharyngeal or oesophageal candidiasis in patients infected with hiv who are at high risk of experiencing relapse.• prophylaxis of candidal infections in patients with prolonged neutropenia (such as patients with haematological malignancies receiving chemotherapy or patients receiving hematopoietic stem cell transplantation ).stabilanol is indicated in term newborn infants, infants, toddlers, children and adolescents aged from 0 to 17 years old: stabilanol is used for the treatment of mucosal candidiasis (oropharyngeal, oesophageal), invasive candidiasis, cryptococcal meningitis and the prophylaxis of candidal infections in immunocompromised patients. stabilanol can be used as maintenance therapy to prevent relapse of cryptococcal meningitis in children with high risk of reoccurrence.therapy may be instituted before the results of the cultures and other laboratory studies are known; however, once these results become available, anti-infective therapy should be adjusted accordingly.consideration should be given to official guidance on the appropriate use of antifungals.

Israel - engelsk - Ministry of Health

trima israel pharmaceutical products maabarot ltd - fluconazole - solution for infusion - fluconazole 2 mg/ml - fluconazole - fluconazole - stabilanol is indicated in the following fungal infections .stabilanol is indicated in adults for the treatment of: • cryptococcal meningitis .• coccidioidomycosis. invasive candidiasis.• mucosal candidiasis including oropharyngeal, oesophageal candidiasis, candiduria and chronic mucocutaneous candidiasis.• chronic oral atrophic candidiasis (denture sore mouth) if dental hygiene or topical treatment are insufficient.stabilanol is indicated in adults for the prophylaxis of: • relapse of crytopcoccal meningitis in patients with high risk of recurrence.• relapse of oropharyngeal or oesophageal candidiasis in patients infected with hiv who are at high risk of experiencing relapse.• prophylaxis of candidal infections in patients with prolonged neutropenia (such as patients with haematological malignancies receiving chemotherapy or patients receiving hematopoietic stem cell transplantation ).stabilanol is indicated in term newborn infants, infants, toddlers, children and adolescents aged from 0 to 17 years old: sta

Israel - engelsk - Ministry of Health

trima israel pharmaceutical products maabarot ltd - fluconazole - solution for infusion - fluconazole 2 mg/ml - fluconazole - fluconazole - stabilanol is indicated in the following fungal infections .stabilanol is indicated in adults for the treatment of: • cryptococcal meningitis .• coccidioidomycosis. invasive candidiasis.• mucosal candidiasis including oropharyngeal, oesophageal candidiasis, candiduria and chronic mucocutaneous candidiasis.• chronic oral atrophic candidiasis (denture sore mouth) if dental hygiene or topical treatment are insufficient.stabilanol is indicated in adults for the prophylaxis of: • relapse of crytopcoccal meningitis in patients with high risk of recurrence.• relapse of oropharyngeal or oesophageal candidiasis in patients infected with hiv who are at high risk of experiencing relapse.• prophylaxis of candidal infections in patients with prolonged neutropenia (such as patients with haematological malignancies receiving chemotherapy or patients receiving hematopoietic stem cell transplantation ).stabilanol is indicated in term newborn infants, infants, toddlers, children and adolescents aged from 0 to 17 years old: sta